Assessing the Quality of Life of Patients with Prostate Cancer
Author(s)
Pakai A1, Süsleczné Kiss E2, Csákvári T3, Karácsony I2, Póhr K2, Ferenczy M2, Boncz I4, Oláh A4
1University of Pécs, Pécs, ZA, Hungary, 2University of Pécs, Szombathely, Hungary, 3University of Pecs, Zalaegerszeg, Hungary, 4University of Pécs, Pécs, Hungary
Objectives: Prostate cancer is the most common type of cancer among men. Our aim is to analyse its effect on quality of life (QoL) as well as on urinary and erectile functions of certain treatment methods, socio-demographic factors, and the attendance on PSA-based screening. Methods: A quantitative, cross-sectional study was carried out at the urology department of Kanizsai Dorottya Hospital in Hungary between September 1st 2019 – January 31st 2020 (N=102). Patients were selected with a program „EMMA” through non-probability targeted sampling, based on ICD codes of the disease. Selection criteria were: prostate tumour diagnosed with biopsy or TURP, over 40 years of age, PSA ≥5, Gleason score is between 2-8, stage T1-T3. Patients were excluded if: PSA>200, Gleason score of 9-10, stage >M1b. Self-made and standard questionnaires were used (SF-36, EQ-5D, EPIC) for data collection. χ2-test, independent samples t-test were calculated with SPSS 25.0 and MS Excel programs (p<0.05). Results: There is a significant connection between PSA screening attendance and global QoL (p=0.011), an patients’ age QoL (p=0.027), more precisely: physical functioning (p=0.012), mental health (p=0.027) and bodily pain (p=0.048). Connections between economic status and role functions and physical functioning were not significant (p>0.05). Conclusions: More studies are needed to eliminate side effects, since patient reported QoL is key to choose the proper treatment method.
Conference/Value in Health Info
2020-11, ISPOR Europe 2020, Milan, Italy
Value in Health, Volume 23, Issue S2 (December 2020)
Code
PCN311
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes, Stated Preference & Patient Satisfaction
Disease
Reproductive and Sexual Health